Both of these companies develop therapies using CRISPR gene editing tech, but which is the better investment, Intellia or Editas?
Jun 30, 2021
This biotech firm specializes in CRISPR gene editing to combat diseases but is a long way from going to market; is Editas Medicine a buy?
Jun 10, 2021
Analyst stock picks help you build an expert portfolio on day one